NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2026

Conditions
Congenital Pseudarthrosis of Tibia
Interventions
BIOLOGICAL

NVD-003, an autologous 3D scaffold free osteogenic graft

Bone correction and grafting surgery

Trial Locations (2)

1200

Cliniques Universitaires Saint-Luc, Brussels

21215

Adult/Pediatric Limb Lengthening and Reconstruction - International Center for Limb Lengthening - Rubin Institute for Advanced Orthopedics Baltimore, Baltimore

Sponsors
All Listed Sponsors
lead

Novadip Biosciences

INDUSTRY

NCT05693558 - NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia | Biotech Hunter | Biotech Hunter